Adhesion molecules expression in CLL: Potential impact on clinical and hematological parameters

Area of Science:

• Hematology
• Immunology
• Cell Biology

Background:

• B-cell chronic lymphocytic leukemia (CLL) involves CD5+ B lymphocyte accumulation.
• Altered cell adhesion molecule expression may drive CLL cell trafficking and organ infiltration.
• Chemokines and integrins are key in hematopoietic cell homing and retention.

Purpose of the Study:

• To investigate the status of adhesion molecules in CLL.
• To explore the impact of adhesion molecule expression on hematological and clinical parameters in CLL patients.

Main Methods:

• Studied 78 newly diagnosed CLL patients.
• Performed immunophenotyping on peripheral blood using a chronic lymphoid panel.
• Analyzed adhesion molecules (CD11a, CD11b, CD49d, CD49C, CD29, CD38) via Flow Cytometry with monoclonal antibodies.

Main Results:

• Found positive correlations between several adhesion molecules (e.g., CD38 with CD49d, CD11a with CD11b/CD49d/CD29, CD29 with CD49c/CD49d).
• CD49c negatively correlated with Rai staging (p=0.033).
• CD11a, CD29, and CD49d showed significant associations with splenomegaly and lymphadenopathy, respectively.

Conclusions:

• Adhesion molecule expression levels in CLL appear to influence leukemic cell migration patterns.
• These findings suggest a role for adhesion molecules in the dissemination and organ involvement of CLL.